Chris Wood

Chief Investment Strategist, Healthcare & Biotech

Health & Biotech Market veteran

Chris Wood is Mauldin Economics’ chief investment strategist for healthcare and biotech, as well as the chief investment strategist at RiskHedge, an investment research firm focused on understanding and profiting from disruption.

Prior to his career as a professional analyst, Chris played running back for the Cotton Bowl champion Longhorn football team at the University of Texas. His academic background includes bachelor’s degrees in economics and finance, and an MBA with a concentration in finance.

Chris writes Mauldin Economics’ Transformative Age advisory focused on advances in the science of age reversal.